Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Acadia Pharmaceutica (ACAD)

Acadia Pharmaceutica (ACAD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,493,694
  • Shares Outstanding, K 154,025
  • Annual Sales, $ 223,810 K
  • Annual Income, $ -245,190 K
  • 60-Month Beta 2.78
  • Price/Sales 19.22
  • Price/Cash Flow N/A
  • Price/Book 9.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.37
  • Number of Estimates 7
  • High Estimate -0.34
  • Low Estimate -0.40
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +26.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.32 +3.73%
on 01/06/20
47.22 -13.62%
on 01/10/20
-3.78 (-8.48%)
since 12/23/19
3-Month
39.32 +3.73%
on 01/06/20
53.70 -24.04%
on 12/05/19
-1.02 (-2.44%)
since 10/23/19
52-Week
20.62 +97.82%
on 01/24/19
53.70 -24.04%
on 12/05/19
+19.98 (+96.01%)
since 01/23/19

Most Recent Stories

More News
After Yesterday's Decline of 2.42%, Acadia Pharmaceu Offers Investors Better Value

Acadia Pharmaceu (NASDAQ:ACAD) traded in a range yesterday that spanned from a low of $40.91 to a high of $42.13. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of...

ACAD : 40.79 (-3.25%)
ACADIA (ACAD) Up More Than 100% in the Past Year: Here's Why

ACADIA's (ACAD) only marketed drug Nuplazid registers strong sales in 2019. The drug's label expansion efforts also look promising with several studies currently underway for various CNS disorders.

ACAD : 40.79 (-3.25%)
RGEN : 99.69 (-1.15%)
EPZM : 26.72 (+4.74%)
AXSM : 87.76 (+0.29%)
Acadia Pharmaceu Set to Possibly Pullback After Yesterday's Rally of 3.36%

Acadia Pharmaceu (NASDAQ:ACAD) traded in a range yesterday that spanned from a low of $45.40 to a high of $47.20. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high...

ACAD : 40.79 (-3.25%)
ACADIA Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central...

JPM : 136.54 (-0.10%)
ACAD : 40.79 (-3.25%)
Look for Shares of Acadia Pharmaceu to Potentially Rebound after Yesterday's 1.06% Sell Off

Acadia Pharmaceu (NASDAQ:ACAD) traded in a range yesterday that spanned from a low of $42.43 to a high of $43.17. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of...

ACAD : 40.79 (-3.25%)
Has ACADIA Pharmaceuticals (ACAD) Outpaced Other Medical Stocks This Year?

Is (ACAD) Outperforming Other Medical Stocks This Year?

ACAD : 40.79 (-3.25%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (MRTX, ACAD , NBIX , RGEN , SAGE )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ACAD : 40.79 (-3.25%)
NBIX : 102.18 (-1.21%)
MRTX : 89.33 (-1.82%)
Biotech Stock Outlook: M&A Activity Retains Growth Streak

Biotech Stock Outlook: M&A Activity Retains Growth Streak

VRTX : 233.91 (-0.30%)
REGN : 356.60 (-0.71%)
INCY : 78.24 (-0.31%)
GILD : 63.94 (+0.80%)
ANIK : 45.97 (+0.57%)
ALXN : 108.55 (-2.56%)
ACAD : 40.79 (-3.25%)
SmarTrend Watching for Potential Rebound in Shares of Acadia Pharmaceu After 6.55% Loss

Acadia Pharmaceu (NASDAQ:ACAD) traded in a range yesterday that spanned from a low of $42.87 to a high of $46.51. Yesterday, the shares fell 6.5%, which took the trading range below the 3-day low of...

ACAD : 40.79 (-3.25%)
ACADIA Pharmaceuticals Appoints Stephanie Fagan as Senior Vice President, Corporate Affairs and Chief Communications Officer

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Stephanie Fagan has been appointed to the newly created position of Senior Vice President, Corporate Affairs and Chief Communications Officer....

ACAD : 40.79 (-3.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade ACAD with:

Business Summary

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104...

See More

Key Turning Points

2nd Resistance Point 42.65
1st Resistance Point 41.72
Last Price 40.79
1st Support Level 40.27
2nd Support Level 39.75

See More

52-Week High 53.70
Fibonacci 61.8% 41.06
Last Price 40.79
Fibonacci 50% 37.16
Fibonacci 38.2% 33.26
52-Week Low 20.62

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar